NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-26-281062 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 24, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
120,000
Total Value
$1,659,159.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Ordinary Shares | โ | Jun 22, 2026 | Exercise/Conversion | 25,000 | $10.90 | $272,500.00 | 49,353 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jun 22, 2026 | Exercise/Conversion | 15,000 | $11.90 | $178,500.00 | 64,353 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jun 22, 2026 | Sale | 39,700 | $30.20 | $1,198,940.00 | 24,653 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jun 22, 2026 | Sale | 300 | $30.73 | $9,219.00 | 24,353 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | Jun 22, 2026 | Exercise/Conversion | 25,000 | $0.00 | $0.00 | 43,134 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | Jun 22, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 35,000 | Direct | โ | View Details |